Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Abrams

Showing results (171-180 of 241) with videos related to

Pageof 25
Sort By:
The Journal of Urology|August 18, 2004
Clinical experiences with desmopressin for long-term treatment of nocturiaG Lose, A Mattiasson, S Walter, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 11, 2002
Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-qK Coyne, D Revicki, T Hunt, et al.
Journal of Pediatric Urology|October 25, 2008
Trying to predict 'dangerous' bladders in children: the area under the curve conceptH Hashim, J Ellis-Jones, L Swithinbank, et al.
The Journal of Urology|October 1, 1989
Terodiline: a dose titrated, multicenter study of the treatment of idiopathic detrusor instability in womenA Tapp, M Fall, J Norgaard, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Morning vs evening dosing with doxazosin in benign prostatic hyperplasia: efficacy and safetyR S Kirby, C R Chapple, K Sethia, et al.
World Journal of Urology|May 26, 2001
Treatment of overactive bladder: long-term tolerability and efficacy of tolterodineR A Appell, P Abrams, H P Drutz, et al.
Cancer Detection and Prevention|January 1, 1991
Immunoconjugates of Pseudomonas exotoxin A: evaluation in mice, monkeys, and manA C Morgan, R Manger, J W Pearson, et al.
Journal of Anxiety Disorders|April 14, 2009
Pain-related anxiety and anxiety sensitivity across anxiety and depressive disordersR Nicholas Carleton, Murray P Abrams, Gordon J G Asmundson, et al.
The Prostate|October 12, 2000
International Consultation on Urological Diseases: a decade of progressS Khoury, A Cockett, Y Aso, et al.
Drugs & Aging|August 3, 2001
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodineP Abrams, J Malone-Lee, B Jacquetin, et al.
Pageof 25

Showing results (171-180 of 241) with videos related to

Sort By:
Pageof 25
The Journal of Urology|August 18, 2004
Clinical experiences with desmopressin for long-term treatment of nocturiaG Lose, A Mattiasson, S Walter, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|September 11, 2002
Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-qK Coyne, D Revicki, T Hunt, et al.
Journal of Pediatric Urology|October 25, 2008
Trying to predict 'dangerous' bladders in children: the area under the curve conceptH Hashim, J Ellis-Jones, L Swithinbank, et al.
The Journal of Urology|October 1, 1989
Terodiline: a dose titrated, multicenter study of the treatment of idiopathic detrusor instability in womenA Tapp, M Fall, J Norgaard, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Morning vs evening dosing with doxazosin in benign prostatic hyperplasia: efficacy and safetyR S Kirby, C R Chapple, K Sethia, et al.
World Journal of Urology|May 26, 2001
Treatment of overactive bladder: long-term tolerability and efficacy of tolterodineR A Appell, P Abrams, H P Drutz, et al.
Cancer Detection and Prevention|January 1, 1991
Immunoconjugates of Pseudomonas exotoxin A: evaluation in mice, monkeys, and manA C Morgan, R Manger, J W Pearson, et al.
Journal of Anxiety Disorders|April 14, 2009
Pain-related anxiety and anxiety sensitivity across anxiety and depressive disordersR Nicholas Carleton, Murray P Abrams, Gordon J G Asmundson, et al.
The Prostate|October 12, 2000
International Consultation on Urological Diseases: a decade of progressS Khoury, A Cockett, Y Aso, et al.
Drugs & Aging|August 3, 2001
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodineP Abrams, J Malone-Lee, B Jacquetin, et al.
Pageof 25